GlaxoSmithKline (GB:GSK) has released an update.
Top executives at GlaxoSmithKline, including CEO Emma Walmsley and other senior personnel, have recently increased their stakes in the company. They acquired additional ordinary shares by reinvesting dividends paid to shareholders on July 11, 2024, through the company’s Share Reward Plan. The transactions were carried out on the London Stock Exchange, reflecting a vote of confidence in the company’s financial health.
For further insights into GB:GSK stock, check out TipRanks’ Stock Analysis page.
